Company Filing History:
Years Active: 2003-2010
Title: Jun Yang: Innovator in Cancer Research
Introduction
Jun Yang is a prominent inventor based in Houston, TX, who has made significant contributions to the field of cancer research. He holds 3 patents that focus on innovative methods for determining prognosis and developing therapeutic agents for hyperproliferative diseases, including various types of cancer.
Latest Patents
Yang's latest patents include groundbreaking work on "14-3-3 Zeta over-expression as a poor prognosis factor, and a therapeutic target in multiple cancer types." This patent outlines methods for determining prognosis in subjects with hyperproliferative diseases by assessing the expression and function of 14-3-3 zeta. Additionally, it describes the process of creating pharmaceutical agents that modulate apoptosis, which involves obtaining candidate substances, testing their efficacy, and formulating a pharmaceutical composition that includes the selected candidates. These methods are particularly relevant for treating cancers, such as breast cancer.
Career Highlights
Jun Yang is affiliated with the University of Texas System, where he continues to advance research in cancer therapeutics. His work has the potential to significantly impact treatment options for patients suffering from hyperproliferative diseases.
Collaborations
Yang collaborates with esteemed colleagues, including Dihua Yu and Jun Yao, to further enhance the scope and impact of his research.
Conclusion
Jun Yang's innovative work in cancer research exemplifies the critical role of inventors in developing new therapeutic strategies. His contributions are paving the way for improved prognosis and treatment options for patients facing challenging health conditions.